Skip to content

Clinical trials

Terminated Phase 3 Inflammatory Bowel Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Phase: Phase 3 Status: Terminated Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20061
20091
20101
20113
20121
20142
20161
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bausch Health Americas, Inc.3
University Hospital, Grenoble2
AstraZeneca1
Forest Laboratories1
GlaxoSmithKline1
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives1
InDex Pharmaceuticals1
Janssen Biotech, Inc.1
Massachusetts General Hospital1
Prometheus Laboratories1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases14
Crohn Disease9
Colitis, Ulcerative4
Gastrointestinal Diseases4
Colonic Diseases3
Ulcer3
Colitis2
Digestive System Diseases2
Gastroenteritis2
Intestinal Diseases2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.